Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Boehringer Ingelheim
UBS
Chinese Patent Office
US Army
US Department of Justice
AstraZeneca
Baxter

Generated: April 26, 2018

DrugPatentWatch Database Preview

Ascent Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ASCENT PHARMS INC, and what generic and branded alternatives to ASCENT PHARMS INC drugs are available?

ASCENT PHARMS INC has ten approved drugs.



Summary for Ascent Pharms Inc
US Patents:0
Tradenames:7
Ingredients:7
NDAs:10

Drugs and US Patents for Ascent Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascent Pharms Inc OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET;ORAL 210175-002 Feb 2, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Ascent Pharms Inc OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 207419-004 Mar 22, 2017 AA RX No No ➤ Sign Up ➤ Sign Up
Ascent Pharms Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET;ORAL 207416-002 Sep 22, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Ascent Pharms Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride SOLUTION;ORAL 209021-002 Nov 9, 2017 AA RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Colorcon
Daiichi Sankyo
Accenture
US Department of Justice
Queensland Health
Johnson and Johnson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.